In conjunction with SCA’s acquisition of Georgia-Pacific’s European tissue operations during the summer of 2012, the EU Commission imposed requirements concerning the divestment of certain units within consumer tissue. This was communicated in a press release on July 19, 2012. The EU Commission has now approved the divestments.
The requirements imposed by the EU Commission included the sale of parts of Georgia-Pacific’s former operations in the UK, Ireland and the Benelux countries, and certain operations in the Scandinavian region.
The branded business in the UK, Ireland and the Benelux countries is being sold to Sofidel. The production facility in Horwich, UK, is included in this transaction.
The retailer brand businesses in the UK and Ireland are being sold to Northwood & WEPA. The production facility in Bridgend, UK, is included in this transaction.
Parts of the Nordic retailer brand business have been sold to Vajda Papir. The production facility in Drammen, Norway is included in the transaction, together with a conversion line from the facility in Nokia, Finland.
